SCHEMBL3789092

SCHEMBL3789092

O=C(OC=CCc1ccccc1)C1CCC2OC2C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.36
PKM P14618 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAOB P27338 1/20 0.35
TFPI2 P48307 3/20 0.34
TBXA2R P21731 2/20 0.34
TOP1 P11387 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
AKR1C3 P42330 1/20 0.33
AKR1C1 Q04828 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3784914 0.92 MAOB (0.39) LMNAPKML3MBTL1MAOBTBXA2R
SCHEMBL4269550 0.79 SMN1; SMN2 (0.48) LMNAPKML3MBTL1MEN1KMT2A
SCHEMBL4269208 0.79 SMN1; SMN2 (0.48) LMNAPKML3MBTL1MEN1KMT2A
SCHEMBL3345701 0.79 SMN1; SMN2 (0.48) LMNAPKML3MBTL1MEN1KMT2A
SCHEMBL3345699 0.79 SMN1; SMN2 (0.48) LMNAPKML3MBTL1MEN1KMT2A
SCHEMBL715194 0.79 SMN1; SMN2 (0.48) LMNAPKML3MBTL1MEN1KMT2A
SCHEMBL3785863 0.78 MAOB (0.41) LMNAPKML3MBTL1MAOBTOP1
SCHEMBL472140 0.75 MIF (0.41) MAOBTOP1MEN1KMT2AALDH1A1
SCHEMBL26084032 0.75 SMN1; SMN2 (0.45) LMNAPKML3MBTL1MEN1KMT2A
SCHEMBL26261372 0.74 ELANE (0.53) L3MBTL1MEN1KMT2AALDH1A1AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7696366-B2 Production process of bifunctional epoxy monomer by selective oxidation of diolefin compound SHOWA DENKO K.K. (JP) 2010-04-13 US disclosed
EP-1891031-B1 PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND SHOWA DENKO KK (JP) 2009-03-11 EP disclosed
US-20090030217-A1 PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND SHOWA DENKO K.K. (JP) 2009-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030217-A1 PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND DUOX2, DUOX1, DDT LMNA 4639/4885PKM 2560/4885L3MBTL1 3384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.